A

Axsome Therapeutics

AXSM

86.075
USD
-1.255
(-1.44%)
مغلق
حجم التداول
13,709
الربح لكل سهم
0
العائد الربحي
0
P/E
-14
حجم السوق
4,440,018,963
أصول ذات صلة
A
ACAD
-0.020
(-0.11%)
19.000 USD
A
AVDL
0.135
(0.83%)
16.490 USD
C
CRBP
-0.500
(-0.84%)
59.160 USD
E
EOLS
1.660
(13.38%)
14.070 USD
E
ESPR
-0.13000
(-5.62%)
2.18500 USD
I
ITCI
0.260
(0.33%)
79.030 USD
K
KPTI
-0.06290
(-6.37%)
0.92380 USD
P
PRQR
-0.10000
(-5.24%)
1.81000 USD
S
SAGE
-1.21000
(-11.03%)
9.76000 USD
الأخبار المقالات

العنوان: Axsome Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.